Skip to main content
Clinical Trials/CTRI/2023/06/053822
CTRI/2023/06/053822
Not yet recruiting
Phase 4

A Comparative study to Evaluate the Efficacy and Safety of Imeglimin with Metformin versus Metformin in Type 2 Diabetes Mellitus patients in a tertiary care hospital,Chengalpattu-A Randomised Controlled Trial

Dr Shaki Sam0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
Dr Shaki Sam
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Shaki Sam

Eligibility Criteria

Inclusion Criteria

  • 1\)Male \& Female population
  • 2\)HbA1c \>6\.5 and \<10
  • 3\)Patients willing to participate and given written informed consent

Exclusion Criteria

  • 1\)Those who are on insulin therapy or any injectable glucose lowering drugs in the past 30 days.
  • 2\)Pregnant and lactating mother
  • 3\)Patients with impaired hepatic or renal function
  • 4\)Patients with hypertension,congestive cardiac failure,ischemic heart disease.
  • 5\)Clinically significant micro vascular and macro vascular complications
  • 6\)Patients who didnâ??t give written informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials